Figure 1 | Leukemia

Figure 1

From: Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia

Figure 1

DFCI ALL Consortium Protocol flow diagram. One hundred patients with newly diagnosed ALL were enrolled. Ninety-two patients were considered eligible, of whom 78 (85%) achieved a complete remission within 1 month. Fifty-seven were evaluable for the asparaginase feasibility end point. All 92 patients were evaluable for analysis of EFS and OS.

Back to article page